{"id":"https://openalex.org/W4249986230","doi":"https://doi.org/10.26226/morressier.57d6994fd462b80290b4d4b8","title":"REPLACEMENT IMMUNOTHERAPY FOR SECONDARY IMMUNODEFICIENCY ASSOCIATED WITH HAEMATOLOGICAL MALIGNANCY. PART 2: EFFICACY, SAFETY AND TREATMENT EVOLUTION DURING A 12-MONTH FOLLOW-UP: THE EPICURE STUDY","display_name":"REPLACEMENT IMMUNOTHERAPY FOR SECONDARY IMMUNODEFICIENCY ASSOCIATED WITH HAEMATOLOGICAL MALIGNANCY. PART 2: EFFICACY, SAFETY AND TREATMENT EVOLUTION DURING A 12-MONTH FOLLOW-UP: THE EPICURE STUDY","publication_year":2016,"publication_date":"2016-09-12","ids":{"openalex":"https://openalex.org/W4249986230","doi":"https://doi.org/10.26226/morressier.57d6994fd462b80290b4d4b8"},"language":"en","primary_location":{"id":"doi:10.26226/morressier.57d6994fd462b80290b4d4b8","doi":"https://doi.org/10.26226/morressier.57d6994fd462b80290b4d4b8","is_oa":false,"landing_page_url":"https://doi.org/10.26226/morressier.57d6994fd462b80290b4d4b8","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111852008","display_name":"Jean\u2010Charles Crave","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jean-charles Crave","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111852008"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.7939000129699707,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.13819999992847443,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.02070000022649765,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-immunodeficiency","display_name":"secondary immunodeficiency","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8349999785423279},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/immunoglobulin-replacement-therapy","display_name":"immunoglobulin replacement therapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.652999997138977},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.9559999704360962},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.8610000014305115}],"concepts":[{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.7721822261810303},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7430005073547363},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6923277974128723},{"id":"https://openalex.org/C2777607303","wikidata":"https://www.wikidata.org/wiki/Q641307","display_name":"Immunodeficiency","level":3,"score":0.60630202293396},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5045522451400757},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33750009536743164},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24312418699264526},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2378968596458435},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1437450647354126}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.26226/morressier.57d6994fd462b80290b4d4b8","doi":"https://doi.org/10.26226/morressier.57d6994fd462b80290b4d4b8","is_oa":false,"landing_page_url":"https://doi.org/10.26226/morressier.57d6994fd462b80290b4d4b8","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4253948225","https://openalex.org/W7006446179","https://openalex.org/W4239403946","https://openalex.org/W2553524921","https://openalex.org/W7217086636","https://openalex.org/W2972417821","https://openalex.org/W2278551485","https://openalex.org/W7117147973","https://openalex.org/W3144434827","https://openalex.org/W3157416296"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2022-05-12T00:00:00"}